Top 3 Competitors in Europe Diabetes Monitoring, Treatment and Drug Delivery Market Examined in iData Research Report
22 Feb 2013 • by Natalie Aster
In 2012, the three largest competitors in the market for diabetes diagnosis, treatment and drug delivery competed exclusively in the insulin and insulin pen markets.
Competition within the total diabetes market was extremely segmented based on market area. Companies with leading shares in the insulin segments also held strong shares in the overall market. These companies include Novo Nordisk, Sanofi and Eli Lilly.
Meanwhile, the traditional blood glucose meter, test strip, lancet and lancing device markets were dominated by several different companies, which have established their shares by offering a large product range and maintaining customer satisfaction in a lucrative marketplace.
According to the report “European Markets for Diabetes Monitoring, Treatment and Drug Delivery” by iData Research, brand recognition allows these large companies to gain the trust of both diabetic patients and their physicians with the knowledge that their glucose monitoring products will provide an accurate and reliable reading to maintain glucose homeostasis.
Units Sold. Insulin Pen Market. U.S. 2008 - 2018
European Markets for Diabetes Monitoring, Treatment and Drug Delivery
Published: February, 2013
Price: US$ 10,995.00
More information can be found in the report “European Markets for Diabetes Monitoring, Treatment and Drug Delivery” by iData Research.
To order the report or ask for sample pages contact [email protected]